Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06557291
What this trial is testing

Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy in Patients With BRAF V600-mutated Stage III/IV Melanoma

Who this might be right for
BRAF V600 Mutated-Stage III/IV Melanoma
Novartis 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT07376317
What this trial is testing

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

Who this might be right for
Melanoma MetastaticMelanoma RecurrentCutaneous Melanoma+1 more
Instituto do Cancer do Estado de São Paulo 29
Testing effectiveness (Phase 2)Study completedNCT03873818
What this trial is testing

Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00288041
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT01107665
What this trial is testing

Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma

Who this might be right for
Stage III MelanomaStage IV MelanomaUnresectable Melanoma
University of California, Irvine 60
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Not applicableStudy completedNCT06180460
What this trial is testing

CALM: Managing Distress in Malignant Brain Cancer

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+5 more
Virginia Commonwealth University 60
Early research (Phase 1)Study completedNCT02935790
What this trial is testing

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma
Celgene 1
Early research (Phase 1)UnknownNCT04197882
What this trial is testing

Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 33
Testing effectiveness (Phase 2)Study completedNCT00104988
What this trial is testing

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 64
Early research (Phase 1)Study completedNCT00091143
What this trial is testing

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04021420
What this trial is testing

Safety and Efficacy of Sonocloud Device Combined With Nivolumab in Brain Metastases From Patients With Melanoma

Who this might be right for
MelanomaMetastatic Melanoma
Assistance Publique - Hôpitaux de Paris 21
Testing effectiveness (Phase 2)Study completedNCT00002535
What this trial is testing

Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
St. Luke's Medical Center
Early research (Phase 1)Study completedNCT00453050
What this trial is testing

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

Who this might be right for
Melanoma (Skin)Metastatic Cancer
University of Oklahoma 11
Not applicableUnknownNCT03132090
What this trial is testing

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

Who this might be right for
Malignant Melanoma Stage IV
University Hospital Tuebingen 106
Testing effectiveness (Phase 2)Study completedNCT00004135
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
University of Chicago 19
Early research (Phase 1)Study completedNCT00034554
What this trial is testing

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 31
Testing effectiveness (Phase 2)UnknownNCT00538005
What this trial is testing

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Melanoma (Skin)
San Diego Pacific Oncology & Hematology Associates 54
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Testing effectiveness (Phase 2)Ended earlyNCT01495988
What this trial is testing

Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma

Who this might be right for
MelanomaMetastatic Melanoma
Melanoma Research Foundation Breakthrough Consortium 10
Next Page